Doctors, patients, and healthcare stakeholders are encouraged to submit comments by November 23 as part of the crucial second round of comments for a proposed new quality measure that seeks to address the underutilization of FDA-approved treatment for African Americans with heart failure. Comments must be submitted now in favor of NQF’s recent report in support of moving ahead with further testing. Currently, thousands of African Americans with heart disease die needlessly every year due to the Nation’s failure to treat them to the acknowledged standard of care. If adopted, the proposed quality measure can help save many lives.
Archives
June 2017
Categories |
